Skip to main navigation Skip to search Skip to main content

An observer-blind study to evaluate the efficacy, safety, reactogenicity and immunogenicity of the GSK Biologicals' investigational vaccine GSK3277511A when administered to COPD patients

Project: Research

Project Details

StatusFinished
Effective start/end date06/25/18 → 06/25/21

Funding

  • GlaxoSmithKline: $11,655.00